Total Payments
$5,318
2024 Payments
$2,765
Companies
34
Transactions
250
Medicare Patients
649
Medicare Billing
$51,147
Payment Breakdown by Category
Food & Beverage$5,314 (99.9%)
Education$3.85 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,314 | 249 | 99.9% |
| Education | $3.85 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,101 | 56 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $854.20 | 33 | $0 (2024) |
| GlaxoSmithKline, LLC. | $378.00 | 12 | $0 (2024) |
| Abbott Laboratories | $376.13 | 17 | $0 (2024) |
| Lilly USA, LLC | $324.20 | 17 | $0 (2024) |
| ABBVIE INC. | $264.73 | 14 | $0 (2024) |
| PFIZER INC. | $237.82 | 16 | $0 (2024) |
| Astellas Pharma US Inc | $235.20 | 10 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $171.04 | 11 | $0 (2019) |
| QOL Medical, LLC | $152.32 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,765 | 119 | AstraZeneca Pharmaceuticals LP ($549.55) |
| 2023 | $1,261 | 53 | Novo Nordisk Inc ($352.43) |
| 2022 | $316.29 | 19 | Novo Nordisk Inc ($158.65) |
| 2021 | $365.95 | 20 | Novo Nordisk Inc ($84.84) |
| 2019 | $43.26 | 3 | Merck Sharp & Dohme Corporation ($15.52) |
| 2018 | $169.15 | 11 | AstraZeneca Pharmaceuticals LP ($47.10) |
| 2017 | $396.03 | 25 | Merck Sharp & Dohme Corporation ($110.44) |
All Payment Transactions
250 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Biological | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.32 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/14/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.71 | General |
| Category: Biological | ||||||
| 11/07/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $36.16 | General |
| Category: THERAPY FOR CSID | ||||||
| 11/06/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $28.40 | General |
| Category: Diabetes | ||||||
| 11/05/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.65 | General |
| Category: Obesity | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Respiratory | ||||||
| 10/29/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $85.11 | General |
| Category: Diabetes Care | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Respiratory | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $42.32 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $130.15 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.47 | General |
| Category: NEUROSCIENCE | ||||||
| 10/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Biological | ||||||
| 10/11/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 282 | 312 | $43,905 | $21,450 |
| 2022 | 5 | 121 | 145 | $19,725 | $8,728 |
| 2021 | 5 | 127 | 173 | $23,965 | $12,214 |
| 2020 | 5 | 119 | 151 | $21,600 | $8,754 |
Total Patients
649
Total Services
781
Medicare Billing
$51,147
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $9,225 | $6,112 | 66.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 39 | 62 | $10,940 | $5,707 | 52.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 42 | 42 | $8,400 | $3,386 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $3,975 | $1,743 | 43.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $1,600 | $1,516 | 94.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 26 | $3,250 | $1,295 | 39.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 39 | 39 | $2,925 | $767.91 | 26.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 20 | $800.00 | $650.00 | 81.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 32 | $2,240 | $255.48 | 11.4% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 11 | 11 | $550.00 | $18.72 | 3.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 26 | 26 | $5,330 | $3,636 | 68.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 43 | $5,375 | $2,428 | 45.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 26 | 36 | $6,120 | $2,068 | 33.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 20 | 20 | $1,500 | $399.46 | 26.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 19 | 20 | $1,400 | $196.97 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 53 | $9,010 | $4,467 | 49.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 30 | 30 | $6,150 | $4,287 | 69.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 43 | $5,375 | $2,711 | 50.4% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 28 | 28 | $2,100 | $572.32 | 27.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 19 | 19 | $1,330 | $176.43 | 13.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 28 | 28 | $5,740 | $3,509 | 61.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 48 | $8,160 | $3,099 | 38.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 29 | 43 | $5,375 | $1,671 | 31.1% |
| G0444 | Annual depression screening, 15 minutes | Office | 2020 | 17 | 17 | $1,275 | $326.28 | 25.6% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 15 | 15 | $1,050 | $149.70 | 14.3% |
About Dr. Rochelle Collins, DO
Dr. Rochelle Collins, DO is a Family Medicine healthcare provider based in Bloomfield, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205847241.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rochelle Collins, DO has received a total of $5,318 in payments from pharmaceutical and medical device companies, with $2,765 received in 2024. These payments were reported across 250 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,314).
As a Medicare-enrolled provider, Collins has provided services to 649 Medicare beneficiaries, totaling 781 services with total Medicare billing of $51,147. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bloomfield, CT
- Active Since 08/11/2006
- Last Updated 09/09/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205847241
Products in Payments
- BREZTRI (Drug) $456.69
- Ozempic (Drug) $317.11
- FREESTYLE LIBRE 3 (Device) $314.67
- Rybelsus (Drug) $292.51
- AIRSUPRA (Drug) $281.14
- Wegovy (Drug) $242.09
- Veozah (Drug) $235.20
- TRELEGY ELLIPTA (Drug) $223.81
- VRAYLAR (Drug) $213.26
- MOUNJARO (Drug) $184.99
- JANUVIA (Drug) $156.00
- SUCRAID (Drug) $152.32
- NURTEC ODT (Drug) $135.06
- REXULTI (Drug) $131.43
- FARXIGA (Drug) $112.52
- Cologuard Collection Kit (Device) $112.32
- JARDIANCE (Drug) $104.54
- XYOSTED (Drug) $100.17
- CONTRAVE (Drug) $88.87
- XIFAXAN (Drug) $87.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bloomfield
Gilberto Ramirez, Md, MD
Family Medicine — Payments: $13,439
Family Medicine $13,439
Mrs. Hemlata Bhatia, Md, MD
Family Medicine — Payments: $4,980
Family Medicine $4,980
Kennett Asher, D. O, D. O
Family Medicine — Payments: $4,833
Family Medicine $4,833
Yasmen Srour, M.d, M.D
Family Medicine — Payments: $2,886
Family Medicine $2,886
Christine Hanna, Md, MD
Family Medicine — Payments: $2,115
Family Medicine $2,115
Dr. Donald Wirtanen, D.o, D.O
Family Medicine — Payments: $1,388
Family Medicine $1,388